Mus vs Slovenia: HIV-positive TB patients on ART (antiretroviral therapy)
Mus
100.0%
in 2024
Slovenia
100.0%
in 2024
Mus rank
1st
Slovenia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Mus
- Slovenia
How they compare
Mus currently reports 100.0% against 100.0% in Slovenia, a difference of 0.0%.
Across all 6 years both countries report, Slovenia has been ahead every year.
Mus ranks 1st and Slovenia ranks 1st of 2 regions.
Slovenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.0% | 100.0% | 10.0% | Slovenia |
| 2010s | 93.7% | 100.0% | 6.3% | Slovenia |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Mus or Slovenia?
- Mus, at 100.0% against 100.0% in Slovenia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Mus and Slovenia?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Slovenia?
- 6 years are reported by both, from 2004 to 2024.
- How do Mus and Slovenia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Mus ranks 1st and Slovenia ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.